411 related articles for article (PubMed ID: 18805273)
1. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years.
Yankah CA; Pasic M; Musci M; Stein J; Detschades C; Siniawski H; Hetzer R
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):688-96. PubMed ID: 18805273
[TBL] [Abstract][Full Text] [Related]
2. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position.
Yankah CA; Schubel J; Buz S; Siniawski H; Hetzer R
J Heart Valve Dis; 2005 Mar; 14(2):172-9; discussion 179-80. PubMed ID: 15792176
[TBL] [Abstract][Full Text] [Related]
3. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors.
Minami K; Boethig D; Mirow N; Kleikamp G; Koertke H; Godehardt E; Koerfer R
J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383
[TBL] [Abstract][Full Text] [Related]
4. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients.
Minami K; Zittermann A; Schulte-Eistrup S; Koertke H; Körfer R
Ann Thorac Surg; 2005 Nov; 80(5):1699-705. PubMed ID: 16242441
[TBL] [Abstract][Full Text] [Related]
5. CarboMedics Mitroflow pericardial aortic bioprosthesis - performance in patients aged 60 years and older after 15 years.
Benhameid O; Jamieson WR; Castella M; Carrier M; Pomar JL; Germann E; Pellerin M; Brownlee RT
Thorac Cardiovasc Surg; 2008 Jun; 56(4):195-9. PubMed ID: 18481236
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement.
Sjögren J; Gudbjartsson T; Thulin LI
J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900
[TBL] [Abstract][Full Text] [Related]
7. Twenty-year clinical experience with porcine bioprostheses.
Fann JI; Miller DC; Moore KA; Mitchell RS; Oyer PE; Stinson EB; Robbins RC; Reitz BA; Shumway NE
Ann Thorac Surg; 1996 Nov; 62(5):1301-11; discussion 1311-2. PubMed ID: 8893561
[TBL] [Abstract][Full Text] [Related]
8. Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study.
Takkenberg JJ; Klieverik LM; Bekkers JA; Kappetein AP; Roos JW; Eijkemans MJ; Bogers AJ
Eur J Cardiothorac Surg; 2007 May; 31(5):851-9. PubMed ID: 17350857
[TBL] [Abstract][Full Text] [Related]
9. The Mitroflow pericardial bioprosthesis. Comparison of early clinical performance in aortic and mitral positions.
Jamieson WR; Pelletier LC; Gerein AN; Pomar J
Can J Surg; 1992 Apr; 35(2):159-64. PubMed ID: 1562925
[TBL] [Abstract][Full Text] [Related]
10. Lack of durability of the Mitroflow valve does not affect survival.
Houel R; Le Besnerais P; Soustelle C; Kirsch M; Hillion ML; Loisance D
J Heart Valve Dis; 1999 Jul; 8(4):368-74; discussion 374-5. PubMed ID: 10461235
[TBL] [Abstract][Full Text] [Related]
11. Durability of pericardial versus porcine aortic valves.
Gao G; Wu Y; Grunkemeier GL; Furnary AP; Starr A
J Am Coll Cardiol; 2004 Jul; 44(2):384-8. PubMed ID: 15261935
[TBL] [Abstract][Full Text] [Related]
12. The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients.
Aupart MR; Sirinelli AL; Diemont FF; Meurisse YA; Dreyfus XB; Marchand MA
Ann Thorac Surg; 1996 Feb; 61(2):615-20. PubMed ID: 8572776
[TBL] [Abstract][Full Text] [Related]
13. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
[TBL] [Abstract][Full Text] [Related]
14. Twenty-year results of the Hancock II bioprosthesis.
Borger MA; Ivanov J; Armstrong S; Christie-Hrybinsky D; Feindel CM; David TE
J Heart Valve Dis; 2006 Jan; 15(1):49-55; discussion 55-6. PubMed ID: 16480012
[TBL] [Abstract][Full Text] [Related]
15. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.
García-Bengochea J; Sierra J; González-Juanatey JR; Rubio J; Vega M; Fernández AL; Sánchez D
J Heart Valve Dis; 2006 May; 15(3):446-51; discussion 451-2. PubMed ID: 16784087
[TBL] [Abstract][Full Text] [Related]
17. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients.
Aupart MR; Mirza A; Meurisse YA; Sirinelli AL; Neville PH; Marchand MA
J Heart Valve Dis; 2006 Nov; 15(6):768-75; discussion 775-6. PubMed ID: 17152784
[TBL] [Abstract][Full Text] [Related]
18. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
Mykén PS
J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
[TBL] [Abstract][Full Text] [Related]
19. Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesis.
Emery RW; Arom KV; Kshettry VR; Kroshus TJ; Von R; Kersten TE; Lillehei TJ; Nicoloff DM; Erickson CA
J Heart Valve Dis; 2002 Jan; 11 Suppl 1():S37-44. PubMed ID: 11843519
[TBL] [Abstract][Full Text] [Related]
20. Biological versus mechanical aortic prosthesis? A nineteen-year comparison in a propensity-matched population.
Bottio T; Rizzoli G; Caprili L; Testolin L; Thiene G; Gerosa G
J Heart Valve Dis; 2005 Jul; 14(4):493-500. PubMed ID: 16116876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
